Nebulization: A potential source of SARS-CoV-2 transmission.

Reychler, G; Vecellio, L; Dubus, J C

Reychler, G; Vecellio, L; Dubus, J C.

Reychler G; Service de Pneumologie, Cliniques universitaires Saint-Luc, Avenue Hippocrate 10, 1200 Bruxelles, Belgique. Electronic address: gregory.reychler@uclouvain.be.
Vecellio L; CEPR-INSERM U1100, Université de Tours, Faculté de Médecine, 37032 Tours cedex, France.
Dubus JC; Pneumologie Pédiatrique, CHU Timone-Enfants, et Aix-Marseille Université, IRD, MEPHI, IHU Méditerranée-Infection, 13385 Marseille Cedex 5, France.

Respir Med Res ; 78: 100778, 2020 11.

Article in English | MEDLINE | ID: covidwho-693156

Subject(s)

COVID-19/transmission; Nebulizers and Vaporizers/virology; Respiratory Therapy/adverse effects; SARS-CoV-2/physiology; Administration, Inhalation; Aerosols/adverse effects; COVID-19/epidemiology; Cross Infection/epidemiology; Cross Infection/prevention & control; Disease Transmission, Infectious/prevention & control; Disease Transmission, Infectious/statistics & numerical data; Equipment Contamination/statistics & numerical data; Humans; Oxygen Inhalation Therapy/adverse effects; Oxygen Inhalation Therapy/methods; Pandemics; Respiratory Therapy/methods; Risk Factors; SARS-CoV-2/isolation & purification

Keywords

Antifungal drugs; Azoles; Mucorales; Nebulization; Polyenes; Prophylaxis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Therapy / Nebulizers and Vaporizers / SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Respir Med Res Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google